Zenas BioPharma to present obexelimab data at IGG4ward symposium
Zenas BioPharma said it will present upcoming obexelimab data in IGG4-related disease at the IGG4ward! 6th International Symposium on IGG4-related Disease and ACR Convergence 2026.
Zenas BioPharma said it will present upcoming obexelimab data in IGG4-related disease at the IGG4ward! 6th International Symposium on IGG4-related Disease and ACR Convergence 2026.